Home > Antibodies > GeneAb™ p27 Antibody

GeneAb<sup>TM</sup> p27 [IHC027] on Lymph Node Coming Soon

Coming Soon

GeneAb<sup>TM</sup> p27 [IHC027] on Lymph Node Coming Soon

Reference Panels

Breast/Gynecological Pathology

Dermatopathology

Gastrointestinal (GI) Pathology

Genitourinary (GU) Pathology

Head and Neck Pathology

Hematopathology

Neuropathology

Pediatric Pathology

Pulmonary Pathology

Soft Tissue Pathology

Cytopathology

GeneAb™

p27

(In the pipeline)

Select Format:

Concentrate

Predilute

Positive Control Slides

Select Volume:

0.1 ml	1 ml
7 ml	25 ml
3 slides/package

Price:

$150.00

Quantity:

Cat. No.

IHC027-100

Inquire

Description

p27, also known as p27Kip1, is a cyclin-dependent kinase inhibitor that binds to and inhibits cyclin-dependent kinases, thereby regulating progression from G1 to S phase. Decreased expression of p27 is linked to poor prognosis in renal-cell carcinoma, colon carcinoma, small breast carcinomas, non-small-cell lung carcinoma, hepatocellular carcinoma, multiple myeloma, lymph node metastases in papillary carcinoma of the thyroid, and is associated with a more aggressive phenotype of carcinoma in the cervix.

References
1. Lloyd RV, et al. Am J Pathol. 1999; 154:313-23.
2. Migita T, et al. Cancer. 2002; 94:973-9.
3. Haitel A, et al. Urology. 2001; 58:477-81.
4. Esposito V, et al. Cancer Res. 1997; 57:3381-5.
5. Tan P, et al. Cancer Res. 1997; 57:1259-63
6. Khoo ML, et al. J Clin Endocrinol Metab. 2002; 87:1814-8.
7. Huang LW, et al. Gynecol Oncol. 2002; 85:524-8.
8. Ribal MJ, et al. Anticancer Res. 2003; 23:5101-6.
9. Khoo ML, et al. Arch Otolaryngol Head Neck Surg. 2002; 128:253-7.
10. Freedland SJ, et al. Urology. 2003; 61:1187-92.
11. Armengol C, et al. J Hepatol. 2003; 38:591-7.

Specifications

Clone IHC027

Source Mouse Monoclonal

Positive Control Tonsil

Dilution Range 1:100 - 1:400

Literature

Data Sheet

SDS Sheet

Recommended products

GeneAb<sup>TM</sup> Annexin A1 [IHC512] on Spleen — Annexin A1 (IHC512)

GeneAb<sup>TM</sup> CA-125 [IHC125] on Ovary — CA-125 (IHC125)

GeneAb<sup>TM</sup> CD138 [IHC138] on Liver Cancer — CD138 (IHC138)

GeneAb<sup>TM</sup> CD15/Leu-M1 [IHC527] on Cervical Cancer — CD15/Leu-M1 (IHC527)

GeneAb<sup>TM</sup> CD2 [IHC531] on Tonsil — CD2 (IHC531)

GeneAb<sup>TM</sup> CD44 [IHC044] on Breast Cancer — CD44 (IHC044)

GeneAb<sup>TM</sup> CD45 (LCA) [IHC045] on Tonsil — CD45 (LCA) (IHC045)

GeneAb<sup>TM</sup> CD45R [IHC536] on Tonsil — CD45R (IHC536)

GeneAb<sup>TM</sup> CD5 [IHC538] on Tonsil — CD5 (IHC538)

GeneAb<sup>TM</sup> CD56 [IHC056] on Adrenal Gland — CD56 (IHC056)

GeneAb<sup>TM</sup> CD57 [IHC539] on Tonsil — CD57 (IHC539)

GeneAb<sup>TM</sup> Cytokeratin 18 [IHC018] on Colon - 10X — Cytokeratin 18 (IHC018)

GeneAb<sup>TM</sup> E-cadherin [IHC564] on Breast - 10X — E-cadherin (IHC564)

GeneAb<sup>TM</sup> GATA3 [IHC583] on Breast Cancer — GATA3 (IHC583)

GeneAb<sup>TM</sup> Glycophorin A [IHC587] on Spleen — Glycophorin A (IHC587)

GeneAb<sup>TM</sup> Hairy Cell Leukemia [IHC687] on Lymphoma — Hairy Cell Leukemia (IHC687)

GeneAb<sup>TM</sup> hENT1 [IHC595] on Thyroid Cancer — hENT1 (IHC595)

GeneAb<sup>TM</sup> Her2/Neu [IHC002] on Breast — HER2/neu (IHC002)

GeneAb<sup>TM</sup> Kappa [IHC610] on Ovary — Kappa (IHC610)

GeneAb<sup>TM</sup> Ki-67 [IHC067] on Cervical Cancer - 10X — Ki-67 (IHC067)

GeneAb<sup>TM</sup> LMO2 [IHC615] on Tonsil — LMO2 (IHC615)

GeneAb<sup>TM</sup> p16<sup>INK4A</sup> [IHC116] on Cervical Cancer — p16 (IHC116)

GeneAb<sup>TM</sup> PAX-5 [IHC005] on Tonsil — PAX-5 (IHC005)

GeneAb<sup>TM</sup> PAX-8 [IHC008] on Kidney — PAX8 (IHC008)

GeneAb<sup>TM</sup> PD-1 [IHC001] on Tonsil — PD-1 (IHC001)

GeneAb<sup>TM</sup> PD-L1 [IHC411] on Lung — PD-L1 (IHC411)

GeneAb<sup>TM</sup> SOX-11 [IHC011] on Lymphoma — SOX-11 (IHC011)

GeneAb<sup>TM</sup> TIM3 [IHC003] on Kidney — TIM3 (IHC003)

GeneAb<sup>TM</sup> Vimentin [IHC684] on Colon — Vimentin (IHC684)

#1 - 3691 Viking Way

Richmond, BC V6V 2J6

[email protected]

(604) 244-9962

Copyright © 2019 GenomeMe^TM